Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]

Abstract

Yousefpour P, Atyabi F, Vasheghani-Farahani E, Movahedi M, Dinarvand R. Int J Nanomedicine. 2011;6:1977—1990. The authors have advised Figure 9D on page 1986 is incorrect. Due to an error at the time of figure assembly Figure 9B and D were duplicated. The correct Figure 9 is shown below. Figure 9 Fluorescence microscopy of cellular uptake of (A) trastuzumab-decorated chitosan-doxorubicin conjugated nanoparticles by SKOV-3 cell line, (B) trastuzumab-decorated chitosan-doxorubicin conjugated nanoparticles by MCF-7 cell line, (C) chitosan-doxorubicin conjugated nanoparticles by SKOV-3 cell line, and (D) chitosan-doxorubicin conjugated nanoparticles by MCF-7 cell line. (E) SKOV-3 cells and (F) MCF-7 cells in cell culture medium served as negative controls. The authors previously requested a corrigendum to correct this error soon after publication but it was not actioned due to communication issues between the journal and authors. The authors have now contacted the journal again several years later to request the same corrigendum in relation to the same error. The authors apologize for the error and advise it does not affect the results of the paper.

Keywords

• chitosan
• doxorubicin
• self-assembled nanoparticles
• active targeting
• herceptin